These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 24119342

  • 1. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A, Lauria G, Grimod G, Bianchi G, Salmaggi A.
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [Abstract] [Full Text] [Related]

  • 2. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S, Radhakrishnan K.
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [Abstract] [Full Text] [Related]

  • 3. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B, Rekarte García S, García López JE, Pérez González C, Montes Granda M, Coto Cotallo GD.
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [Abstract] [Full Text] [Related]

  • 4. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C, Marinaki S, Darema M, Skalioti C, Efthimiou A, Zavos G, Boletis JN.
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF, Chen CY.
    Ren Fail; 2008 Jul; 30(8):822-4. PubMed ID: 18791959
    [Abstract] [Full Text] [Related]

  • 8. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB, Kutlu G, Cavdar L, Sanivar F, Inan LE.
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC, van Meijel JJ.
    Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
    [Abstract] [Full Text] [Related]

  • 17. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
    Chopra A, Kolla BP, Mansukhani MP, Netzel P, Frye MA.
    Gen Hosp Psychiatry; 2012 Sep; 34(3):290-8. PubMed ID: 22305367
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Valproate-induced hyperammonemia and seizures: perioperative concerns.
    Garg R, Sunder RA.
    Paediatr Anaesth; 2011 Oct; 21(10):1084-5. PubMed ID: 21981101
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.